Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jul;16 Suppl 5(0 5):67-73.
doi: 10.1111/j.1365-2516.2010.02296.x.

von Willebrand's disease diagnosis and laboratory issues

G Castaman  1 , R R Montgomery, S S Meschengieser, S L Haberichter, A I Woods, M A Lazzari
Affiliations
Review

von Willebrand's disease diagnosis and laboratory issues

G Castaman et al. Haemophilia. 2010 Jul.

Abstract

In this paper, the recent developments in the diagnosis and laboratory issues of von Willebrand's disease (VWD) are presented. Dr. Castaman reviews the functional tests available for the diagnosis of VWD and their pathophysiological significance, focusing on which tests are best used in the diagnosis and classification of VWD. Dr Montgomery reviews an emerging issue that is accelerated clearance of von Willebrand factor (VWF) occurring in some variants of VWD. This phenotype can be suspected by the presence of an increased ratio between the VWF propeptide and the VWF antigen. These patients have typically a robust, but short-lived increase of FVIII and VWF after desmopressin. Dr Meschengieser reviews the determinants of bleeding after surgery in patients with VWD, emphasizing the role of bleeding history in predicting this risk.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. De Meyer SF, Deckmyn H, Vanhoorelbeke K. von Willebrand factor to the rescue. Blood. 2009;113:5049–57. - PubMed
    1. Ruggeri ZM. Old concepts and new developments in the study of platelet aggregation. J Clin Invest. 2000;105:699–701. - PMC - PubMed
    1. Castaman G, Tosetto A, Rodeghiero F. von Willebrand disease. In: Key N, O’Shaughnessy D, Makris M, Lillicrap D, editors. Practical Hemostasis and Thrombosis. Wiley-Blackwell; Oxford: 2009. pp. 73–87.
    1. Vanhoorelbeke K, Cauwenberghd N, Vauterin S, Deckmyn H. A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor. Thromb Haemost. 2000;83:107–13. - PubMed
    1. Federici AB, Canciani MT, Forza I, et al. A sensitive ristocetin cofactor assay with recombinat glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels. Haematologica. 2004;89:77–85. - PubMed

MeSH terms